Apoplogic Pharmaceuticals, Inc.

Aurora, CO 80010

SBIR Award Summary

Total Number of Awards 2
Total Value of Awards $665K
First Award Date 09/30/06
Most Recent Award Date 09/01/07

Key Personnel

Last Name Name Awards Contact
Bellgrau Donald Bellgrau 2

2 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-06
Budget: 09/01/07 - 08/31/09

DESCRIPTION (provided by applicant): Project Summary/Abstract: We have shown that Fas ligand (FasL) gene therapy induces protective immune responses in rodent models. Yet, despite these unquestioned benefits to study mechanistic questions, various factors preclude precise extrapolation of safety data from rodent gene therapy studies to human tri...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-06
Budget: 09/30/06 - 08/31/07

DESCRIPTION (provided by applicant): Project Summary/Abstract: We have shown that Fas ligand (FasL) gene therapy induces protective immune responses in rodent models. Yet, despite these unquestioned benefits to study mechanistic questions, various factors preclude precise extrapolation of safety data from rodent gene therapy studies to human tri...